WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Atara Biotherapeutics, Inc. (NASDAQ: ATRA) between May 20, 2024 and January 9, 2026, inclusive (the “Class ...
Representatives from major banks, insurers and exchanges expected to be briefed on cyber security risks posed by Claude ...
The earnings season kicks into high gear this week, at a time when investors may be starving for corporate guidance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results